Publication | Closed Access
Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty
82
Citations
19
References
1996
Year
Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseAtherosclerosisSurgeryEndovascular ManagementNeovascularizationPreventive EffectsMedicineCardiologyCoronary Artery Disease
| Year | Citations | |
|---|---|---|
1972 | 32.1K | |
1979 | 2.4K | |
1984 | 1.1K | |
1986 | 626 | |
1987 | 378 | |
1985 | 291 | |
1985 | 203 | |
1989 | 165 | |
1991 | 162 | |
Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Studio Trapidil versus Aspirin nella Restenosi Coronarica. | 1994 | 151 |
Page 1
Page 1